Sulfamethoxazole + Trimethoprim Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 160 mg sulfamethoxazole + 800 mg trimethoprim; 80mg/400 mg
Reference Brands: Bactrim(US), Septra (India), Sulfatrim (EU)
Category:
Antibiotics
Sulfamethoxazole inhibits bacterial folate synthesis, while trimethoprim blocks dihydrofolate reductase, collectively halting bacterial DNA and protein synthesis. This combination offers broad-spectrum activity, effective against urinary, respiratory, and skin infections. Benefits include rapid bacterial eradication, high efficacy, and oral convenience, making it a reliable therapy for various bacterial infections.
Sulfamethoxazole + Trimethoprim tablets is available in Tablet
and strengths such as 160 mg sulfamethoxazole + 800 mg trimethoprim; 80mg/400 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sulfamethoxazole + Trimethoprim tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sulfamethoxazole + Trimethoprim tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sulfamethoxazole + Trimethoprim tablets are approved in both the EU and US for treating urinary, respiratory, and skin bacterial infections. In the EU, brands like Bactrim and Septra are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic options are widely available. Both regions require detailed dossiers, including clinical trial results, manufacturing practices, and pharmacovigilance plans for approval and post-marketing safety. For expert regulatory support, dossier management, and registration, visit PharmaTradz. We facilitate seamless market access, ensuring adherence to European and US standards for safe, effective antibiotic therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing